{"id":"https://openalex.org/W2018912432","doi":"https://doi.org/10.1158/0008-5472.can-07-6226","title":"Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies","display_name":"Complement-Dependent Tumor Cell Lysis Triggered by Combinations of Epidermal Growth Factor Receptor Antibodies","publication_year":2008,"publication_date":"2008-07-01","ids":{"openalex":"https://openalex.org/W2018912432","doi":"https://doi.org/10.1158/0008-5472.can-07-6226","mag":"2018912432","pmid":"https://pubmed.ncbi.nlm.nih.gov/18593896"},"language":"en","primary_location":{"id":"doi:10.1158/0008-5472.can-07-6226","doi":"https://doi.org/10.1158/0008-5472.can-07-6226","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-07-6226","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://dspace.library.uu.nl/handle/1874/32102","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5010859982","display_name":"Michael Dechant","orcid":"https://orcid.org/0000-0003-4024-8353","observed_orcids":["https://orcid.org/0000-0003-4024-8353"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael Dechant","raw_affiliation_strings":["1Department of Nephrology and Hypertension, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Nephrology and Hypertension, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069702765","display_name":"Wencke Weisner","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Wencke Weisner","raw_affiliation_strings":["1Department of Nephrology and Hypertension, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Nephrology and Hypertension, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074416400","display_name":"Sven Berger","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sven Berger","raw_affiliation_strings":["1Department of Nephrology and Hypertension, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Nephrology and Hypertension, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012207265","display_name":"Matthias Peipp","orcid":"https://orcid.org/0000-0002-5088-3804","observed_orcids":["https://orcid.org/0000-0002-5088-3804"]},"institutions":[{"id":"https://openalex.org/I32021983","display_name":"Christian-Albrechts-Universit\u00e4t zu Kiel","ror":"https://ror.org/04v76ef78","country_code":"DE","type":"education","lineage":["https://openalex.org/I32021983"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Matthias Peipp","raw_affiliation_strings":["2Section of Stem Cell Transplantation and Immunotherapy, Christian-Albrechts-University, Kiel, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Section of Stem Cell Transplantation and Immunotherapy, Christian-Albrechts-University, Kiel, Germany;","institution_ids":["https://openalex.org/I32021983"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017696424","display_name":"Thomas D. Beyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Beyer","raw_affiliation_strings":["1Department of Nephrology and Hypertension, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Nephrology and Hypertension, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079273940","display_name":"Tanja Schneider\u2010Merck","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tanja Schneider-Merck","raw_affiliation_strings":["1Department of Nephrology and Hypertension, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Nephrology and Hypertension, and","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055835091","display_name":"Jeroen J. Lammerts van Bueren","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I266595603","display_name":"Genmab (United States)","ror":"https://ror.org/05258cy55","country_code":"US","type":"company","lineage":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]},{"id":"https://openalex.org/I4210163256","display_name":"Genmab (Denmark)","ror":"https://ror.org/057pe1087","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210163256"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Jeroen J. Lammerts van Bueren","raw_affiliation_strings":["3Genmab; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Genmab; and","institution_ids":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109196174","display_name":"Wim K. Bleeker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I266595603","display_name":"Genmab (United States)","ror":"https://ror.org/05258cy55","country_code":"US","type":"company","lineage":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]},{"id":"https://openalex.org/I4210163256","display_name":"Genmab (Denmark)","ror":"https://ror.org/057pe1087","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210163256"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Wim K. Bleeker","raw_affiliation_strings":["3Genmab; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Genmab; and","institution_ids":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5039190287","display_name":"Paul W.H.I. Parren","orcid":"https://orcid.org/0000-0002-4365-3859","observed_orcids":["https://orcid.org/0000-0002-4365-3859"]},"institutions":[{"id":"https://openalex.org/I266595603","display_name":"Genmab (United States)","ror":"https://ror.org/05258cy55","country_code":"US","type":"company","lineage":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]},{"id":"https://openalex.org/I4210163256","display_name":"Genmab (Denmark)","ror":"https://ror.org/057pe1087","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210163256"]}],"countries":["DK","US"],"is_corresponding":false,"raw_author_name":"Paul W.H.I. Parren","raw_affiliation_strings":["3Genmab; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Genmab; and","institution_ids":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111865986","display_name":"Jan G. J. van de Winkel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I266595603","display_name":"Genmab (United States)","ror":"https://ror.org/05258cy55","country_code":"US","type":"company","lineage":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]},{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]},{"id":"https://openalex.org/I4210102253","display_name":"Genmab (Netherlands)","ror":"https://ror.org/01ajp8153","country_code":"NL","type":"company","lineage":["https://openalex.org/I4210102253","https://openalex.org/I4210163256"]},{"id":"https://openalex.org/I4210163256","display_name":"Genmab (Denmark)","ror":"https://ror.org/057pe1087","country_code":"DK","type":"company","lineage":["https://openalex.org/I4210163256"]}],"countries":["DK","NL","US"],"is_corresponding":false,"raw_author_name":"Jan G.J. van de Winkel","raw_affiliation_strings":["3Genmab; and","4Immunotherapy Laboratory, Department of Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands","3Genmab; and; 4Immunotherapy Laboratory, Department of Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Genmab; and","institution_ids":["https://openalex.org/I266595603","https://openalex.org/I4210163256"]},{"raw_affiliation_string":"4Immunotherapy Laboratory, Department of Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916"]},{"raw_affiliation_string":"3Genmab; and; 4Immunotherapy Laboratory, Department of Immunology, University Medical Centre Utrecht, Utrecht, the Netherlands","institution_ids":["https://openalex.org/I3018483916","https://openalex.org/I4210102253"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068320500","display_name":"Thomas Valerius","orcid":"https://orcid.org/0000-0001-9181-8067","observed_orcids":["https://orcid.org/0000-0001-9181-8067"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Valerius","raw_affiliation_strings":["1Department of Nephrology and Hypertension, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Department of Nephrology and Hypertension, and","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":10.4288,"has_fulltext":false,"cited_by_count":165,"citation_normalized_percentile":{"value":0.98768149,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"68","issue":"13","first_page":"4998","last_page":"5003"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5454000234603882,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.5454000234603882,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10993","display_name":"Complement system in diseases","score":0.41769999265670776,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.01720000058412552,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/epidermal-growth-factor-receptor","display_name":"epidermal growth factor receptor","score":0.8980000019073486},{"id":"https://openalex.org/keywords/monoclonal-antibodies","display_name":"monoclonal antibodies","score":0.8109999895095825},{"id":"https://openalex.org/keywords/complement-dependent-cytotoxicity","display_name":"complement-dependent cytotoxicity","score":0.875},{"id":"https://openalex.org/keywords/classical-complement-pathway","display_name":"classical complement pathway","score":0.7390000224113464},{"id":"https://openalex.org/keywords/tumor-cell-lysis","display_name":"tumor cell lysis","score":0.9169999957084656},{"id":"https://openalex.org/keywords/solid-tumors","display_name":"solid tumors","score":0.6169999837875366},{"id":"https://openalex.org/keywords/head-and-neck-cancer","display_name":"head and neck cancer","score":0.7580000162124634},{"id":"https://openalex.org/keywords/colon-cancer","display_name":"colon cancer","score":0.7940000295639038},{"id":"https://openalex.org/keywords/antibody-dependent-cellular-cytotoxicity","display_name":"antibody-dependent cellular cytotoxicity","score":0.8529999852180481}],"concepts":[{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.7856398820877075},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.7234213352203369},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.721929669380188},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.667100191116333},{"id":"https://openalex.org/C2777726029","wikidata":"https://www.wikidata.org/wiki/Q21114926","display_name":"Complement-dependent cytotoxicity","level":5,"score":0.6068525314331055},{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.5922974944114685},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.585326611995697},{"id":"https://openalex.org/C40677261","wikidata":"https://www.wikidata.org/wiki/Q21418091","display_name":"Antibody-dependent cell-mediated cytotoxicity","level":4,"score":0.5473766326904297},{"id":"https://openalex.org/C109316439","wikidata":"https://www.wikidata.org/wiki/Q246181","display_name":"Cytotoxicity","level":3,"score":0.541731059551239},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4749833941459656},{"id":"https://openalex.org/C2778332735","wikidata":"https://www.wikidata.org/wiki/Q417775","display_name":"Panitumumab","level":5,"score":0.4503723680973053},{"id":"https://openalex.org/C111684460","wikidata":"https://www.wikidata.org/wiki/Q334848","display_name":"Complement system","level":3,"score":0.44916707277297974},{"id":"https://openalex.org/C2776362946","wikidata":"https://www.wikidata.org/wiki/Q424374","display_name":"Epidermal growth factor","level":3,"score":0.4317229390144348},{"id":"https://openalex.org/C2777092746","wikidata":"https://www.wikidata.org/wiki/Q5939625","display_name":"Humanized antibody","level":4,"score":0.42684391140937805},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.412602961063385},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3830835521221161},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.11039137840270996},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.08981242775917053}],"mesh":[{"descriptor_ui":"D000068818","descriptor_name":"Cetuximab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077544","descriptor_name":"Panitumumab","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000906","descriptor_name":"Antibodies","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000920","descriptor_name":"Antibody-Dependent Cell Cytotoxicity","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003165","descriptor_name":"Complement System Proteins","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004353","descriptor_name":"Drug Evaluation, Preclinical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007070","descriptor_name":"Immunoglobulin A","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D007140","descriptor_name":"Immunoglobulin Fab Fragments","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D008954","descriptor_name":"Models, Biological","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D014407","descriptor_name":"Tumor Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016923","descriptor_name":"Cell Death","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D016923","descriptor_name":"Cell Death","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D018604","descriptor_name":"Epitope Mapping","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018938","descriptor_name":"Caco-2 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061067","descriptor_name":"Antibodies, Monoclonal, Humanized","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066246","descriptor_name":"ErbB Receptors","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1158/0008-5472.can-07-6226","doi":"https://doi.org/10.1158/0008-5472.can-07-6226","is_oa":false,"landing_page_url":"https://doi.org/10.1158/0008-5472.can-07-6226","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},{"id":"pmid:18593896","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18593896","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer research","raw_type":"Journal Article"},{"id":"pmh:oai:dspace.library.uu.nl:1874/32102","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/32102","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},{"id":"pmh:umcu:oai:dspace.library.uu.nl:1874/32102","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/32102","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research, 68, 4998. American Association for Cancer Research Inc.","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:uu:oai:dspace.library.uu.nl:1874/32102","doi":null,"is_oa":true,"landing_page_url":"http://dspace.library.uu.nl/handle/1874/32102","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Cancer Research, 68, 4998","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:dspace.library.uu.nl:1874/32102","doi":null,"is_oa":true,"landing_page_url":"https://dspace.library.uu.nl/handle/1874/32102","pdf_url":null,"source":{"id":"https://openalex.org/S4306401649","display_name":"Utrecht University Repository (Utrecht University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I193662353","host_organization_name":"Utrecht University","host_organization_lineage":["https://openalex.org/I193662353"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":25,"referenced_works":["https://openalex.org/W315197452","https://openalex.org/W1484094344","https://openalex.org/W1589026573","https://openalex.org/W1600316400","https://openalex.org/W1968961303","https://openalex.org/W1977201631","https://openalex.org/W1978068596","https://openalex.org/W1981608739","https://openalex.org/W1994957566","https://openalex.org/W2000295610","https://openalex.org/W2010690729","https://openalex.org/W2022669521","https://openalex.org/W2039964383","https://openalex.org/W2045156702","https://openalex.org/W2045877726","https://openalex.org/W2106833014","https://openalex.org/W2110243495","https://openalex.org/W2119479524","https://openalex.org/W2130930654","https://openalex.org/W2139195277","https://openalex.org/W2141475443","https://openalex.org/W2158608719","https://openalex.org/W2163332468","https://openalex.org/W2395525054","https://openalex.org/W2405262285"],"related_works":["https://openalex.org/W2534578876","https://openalex.org/W2572862655","https://openalex.org/W2617189466","https://openalex.org/W2501433828","https://openalex.org/W4205720522","https://openalex.org/W2146684793","https://openalex.org/W2146874175","https://openalex.org/W2055179117","https://openalex.org/W2412789061","https://openalex.org/W2129432386"],"abstract_inverted_index":{"Therapeutic":[0],"monoclonal":[1],"antibodies":[2,85,112,130],"against":[3,35,86],"the":[4,12,26,61,97,115],"epidermal":[5],"growth":[6],"factor":[7],"receptor":[8,45],"(EGFR)":[9],"have":[10,37],"advanced":[11],"treatment":[13],"of":[14,28,44,49,60,67,84,103,111,141],"colon":[15],"and":[16,18,21,47,100,152],"head":[17],"neck":[19],"cancer,":[20],"show":[22,76,137],"great":[23],"promise":[24],"for":[25,30,71,80,156],"development":[27],"treatments":[29,155],"other":[31],"solid":[32,157],"cancers.":[33,158],"Antibodies":[34],"EGFR":[36,81,87,143],"been":[38],"shown":[39],"to":[40,149],"act":[41],"via":[42,96],"inhibition":[43],"signaling":[46],"induction":[48],"antibody-dependent":[50],"cellular":[51],"cytoxicity.":[52],"However,":[53],"complement-dependent":[54],"cytotoxicity,":[55],"which":[56,90,122,145],"is":[57,118],"considered":[58],"one":[59],"most":[62],"powerful":[63],"cell":[64],"killing":[65],"mechanisms":[66],"antibodies,":[68,144],"seems":[69],"inactive":[70],"such":[72],"antibodies.":[73,82],"Here,":[74],"we":[75],"a":[77,108,119],"remarkable":[78],"synergy":[79,117],"Combinations":[83],"were":[88],"identified,":[89],"resulted":[91],"in":[92],"potent":[93],"complement":[94],"activation":[95],"classic":[98],"pathway":[99],"effective":[101,154],"lysis":[102],"tumor":[104],"cells.":[105],"Studies":[106],"on":[107],"large":[109],"panel":[110],"indicated":[113],"that":[114],"observed":[116],"general":[120],"mechanism,":[121],"can":[123],"be":[124,147],"activated":[125],"by":[126],"combining":[127],"human":[128],"IgG1":[129],"recognizing":[131],"different,":[132],"nonoverlapping":[133],"epitopes.":[134],"Our":[135],"findings":[136],"an":[138],"unexpected":[139],"quality":[140],"therapeutic":[142],"may":[146],"exploited":[148],"develop":[150],"novel":[151],"more":[153]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":9},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":11},{"year":2016,"cited_by_count":7},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":12},{"year":2012,"cited_by_count":11}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}